Cargando…
Glomerular filtration rate in patients with psoriasis treated with etanercept
OBJECTIVE: To estimate the prevalence of chronic kidney disease (CKD) and evaluate renal function in patients with moderate-to-severe chronic plaque psoriasis treated with etanercept (an anti-tumour necrosis factor-α drug). METHODS: This retrospective cohort study included patients with moderate-to-...
Autores principales: | Gisondi, Paolo, Girolomoni, Giampiero |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536530/ https://www.ncbi.nlm.nih.gov/pubmed/27683151 http://dx.doi.org/10.1177/0300060515613495 |
Ejemplares similares
-
Combination therapy with etanercept in psoriasis: Retrospective analysis of efficacy and safety outcomes from real-life practice
por: Babino, Graziella, et al.
Publicado: (2016) -
Long-term efficacy of high doses of intravenous immunoglobulins in generalized scleromyxoedema: Case report
por: Arginelli, Federica, et al.
Publicado: (2016) -
The role of methotrexate as combination therapy with etanercept in rheumatoid arthritis: Retrospective analysis of a local registry
por: Becciolini, Andrea, et al.
Publicado: (2016) -
From patients’ needs to treatment outcomes in psoriasis: Results from the ‘pSORRIDI’ experience
por: Esposito, Maria, et al.
Publicado: (2016) -
Remission and low disease activity in a cohort of real-life patients with rheumatoid arthritis treated with first-line antitumour necrosis factor
por: Conigliaro, Paola, et al.
Publicado: (2016)